{"id":"NCT03112174","sponsor":"Pharmacyclics LLC.","briefTitle":"Study of Ibrutinib Combined With Venetoclax in Subjects With Mantle Cell Lymphoma (MCL)","officialTitle":"Phase 3 Study of Ibrutinib in Combination With Venetoclax in Subjects With Mantle Cell Lymphoma","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-06-19","primaryCompletion":"2024-06-26","completion":"2024-06-27","firstPosted":"2017-04-13","resultsPosted":"2025-07-22","lastUpdate":"2025-07-22"},"enrollment":366,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Mantle-Cell Lymphoma"],"interventions":[{"type":"DRUG","name":"Ibrutinib","otherNames":[]},{"type":"DRUG","name":"Venetoclax","otherNames":[]},{"type":"DRUG","name":"Placebo Oral tablet to match Venetoclax","otherNames":[]}],"arms":[{"label":"Safety Run-in","type":"EXPERIMENTAL"},{"label":"Randomization Phase: Ibrutinb + Venetoclax","type":"EXPERIMENTAL"},{"label":"Randomization Phase: Ibrutinib + Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Treatment-naive Open-label Arm","type":"EXPERIMENTAL"}],"summary":"This Phase 3 multinational, randomized, double-blind study is designed to compare the efficacy and safety of the combination of ibrutinib and venetoclax vs. ibrutinib and placebo in subjects with MCL.","primaryOutcome":{"measure":"Number of Participants With Tumor Lysis Syndrome (TLS) Events (Safety Run-in)","timeFrame":"After at least 3 months of treatment, with an overall median treatment duration of 20.0 months","effectByArm":[{"arm":"Safety Run-in: Increased TLS Risk at Baseline","deltaMin":1,"sd":null},{"arm":"Safety Run-in: Low TLS Risk at Baseline","deltaMin":0,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":11},"locations":{"siteCount":120,"countries":["United States","Australia","Belgium","Canada","Czechia","France","Germany","Greece","Hungary","Italy","Netherlands","Poland","South Korea","Spain","Turkey (TÃ¼rkiye)","Ukraine","United Kingdom"]},"refs":{"pmids":["39914418","34717692"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":15,"n":15},"commonTop":["DIARRHOEA","FATIGUE","NEUTROPENIA","NAUSEA","COUGH"]}}